Back
ImmunityBio Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Buy
53
IBRX
ImmunityBio
Last Price:
5.04
Seasonality Move:
73.14%
Sell
22
LXRX
Lexicon Pharmaceuticals
Last Price:
0.77
Seasonality Move:
23.34%
Buy
53
ImmunityBio (IBRX)
is a Buy
Is ImmunityBio a Buy, Sell or Hold?
- The current ImmunityBio [IBRX] share price is $5.04. The Score for IBRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- IBRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $0.77. The Score for LXRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IBRX Stock Price Chart
What is ImmunityBio's stock price today?
-
The ImmunityBio share price today is $5.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBRX is experiencing slight buying pressure.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $0.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing selling pressure, which indicates risk of future bearish movement.
IBRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 53.24 | Buy |
| Chaikin Money Flow: | 870465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.2 - 5.66) | Buy |
| Bollinger Bands (100): | (3.54 - 5.58) | Buy |
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 21.01 | Sell |
| Chaikin Money Flow: | -2772797 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.98 - 1.86) | Sell |
| Bollinger Bands (100): | (1.35 - 2.01) | Sell |
IBRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.93 | Buy |
| 20-day SMA: | 5.25 | Sell |
| 50-day SMA: | 4.24 | Buy |
| 200-day SMA: | 5.28 | Sell |
| 8-day EMA: | 5.02 | Buy |
| 20-day EMA: | 4.92 | Buy |
| 50-day EMA: | 4.62 | Buy |
| 200-day EMA: | 4.72 | Buy |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.96 | Sell |
| 20-day SMA: | 1.3 | Sell |
| 50-day SMA: | 1.54 | Sell |
| 200-day SMA: | 1.87 | Sell |
| 8-day EMA: | 0.95 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 1.46 | Sell |
| 200-day EMA: | 1.71 | Sell |
ImmunityBio Earnings Growth & IBRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.32 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.14 per share.
ImmunityBio Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexicon Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||